Optimizing TIL to Expand Patient Reach in Melanoma, Lung & Beyond

Expand patient access in solid tumors with next‑generation TIL, gene editing, harmonized potency and QC frameworks to scale clinical studies to commercial success

With the first TIL Therapy now approved in both the US and Canada, and the field regrouping following a setback in Europe, this is a pivotal time for drug developers looking to address treatment-resistant solid tumors.

Returning for its 8th year, the TIL Therapies Summit remains the go-to forum for this close-knit community, created with the mission to transform end-to-end TIL development and deliver best-in-class therapies to treat solid tumor indications with significant unmet needs.

With more patients being treated than ever, this summit unites a global collective of biopharma, academic thought leaders and clinicians including Curacell, Junecell, Obsidian Therapeutics, AgonOx, as they share their cutting-edge research into engineered TIL, easier manufacturing, QC, Potency, clinical updates, regulatory updates, investment opportunities and more.

The intimate setting really made this conference stand out in my mind compared to others

Senior Director Engineering, Iovance Biotherapeutics

Iovance Biotherapeutics Logo

I liked networking with colleagues in the field; getting the latest updates about TIL therapy development; getting feedback on our cell therapy pipeline

Head of cell therapy, Invios

Invios Logo

An outstanding panel of presenters discussing highly pertinent basic, translational and clinical aspects of TIL therapies. This is one of the best meetings I have had a pleasure to attend.

Director, Cellular Immunotherapy Laboratory, Columbia University

Columbia University Logo

Explore the Full Event Guide

  • 65% Director and above attendees
  • 60+ Attendees
  • 50% C-suite Speaker Faculty
  • 3 days of expert content
  • 1 unmissable meeting
Cover of 7th TIL Therapies Summit Program

Where the TILs Field Comes Together

65%

Director and above attendees

60+

Attendees

20+

Expert speakers

7+

Hours of networking

1

Unmissable meeting

Official Partners

Expertise Partners

Event Partners

Attending Companies Included

KSQ Therapeutics Logo - Company Attending the 7th TIL Therapies Summit
Obsidian Therapeutics Logo - Company Attending the 7th TIL Therapies Summit
CuraCell Logo - Company Attending the 7th TIL Therapies Summit
Neogap Logo - Company Attending the 7th TIL Therapies Summit
AgonOx Logo
Juncell Therapeutics Logo
Tigen Pharma Logo
Achelois Biopharma Logo
Stanford University Logo
Hanson Wade Event Image

Explore the Agenda

Hear the latest breakthroughs for KSQ, Obsidian, AgonOx, in TIL therapy and gain exclusive scientific insights during our packed agenda, interactive roundtables, and expert-led panel discussions.

Hanson Wade Event Image

Partner With Us

Position your brand alongside leading solution providers, the 8th TIL therapies Summit is where you can position your company as the name in TIL therapy.

Hanson Wade Event Image

Join TIL Therapy Experts

Be part of the most important conversations in cell therapy, connecting with attendees spanning every stage of TIL development.